14 min listen
Surviving childhood cancer treatment
FromThe BMJ Podcast
ratings:
Length:
25 minutes
Released:
Jan 21, 2020
Format:
Podcast episode
Description
In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died.
51% had developed a new primary cancer, but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy.
In this podcast we’re joined by Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort
Read the full research:
https://www.bmj.com/content/368/bmj.l6794
51% had developed a new primary cancer, but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy.
In this podcast we’re joined by Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort
Read the full research:
https://www.bmj.com/content/368/bmj.l6794
Released:
Jan 21, 2020
Format:
Podcast episode
Titles in the series (100)
Lost in transfusion?: Blood transfusion is an essential part of modern healthcare and can be lifesaving when used appropriately. In this podcast, Sophie Cook, The BMJ's clinical reviews editor, talks to Michael Murphy, consultant haematologist and professor of blood trans... by The BMJ Podcast